Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD Trial N/A Completed April 26, 2026
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease Trial N/A Not yet recruiting April 26, 2026
Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD Trial N/A Withdrawn April 26, 2026
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders Trial N/A Enrolling by invitation April 23, 2026
Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery Trial Phase 1 Not yet recruiting April 23, 2026
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2 Trial N/A Active, not recruiting April 23, 2026
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus Trial Early Phase 1 Not yet recruiting April 23, 2026
Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease Trial N/A Active, not recruiting April 23, 2026
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease Trial Phase 2 Active, not recruiting April 22, 2026
Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD Trial N/A Recruiting April 22, 2026
Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease Trial N/A Active, not recruiting April 22, 2026
A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease Trial Phase 1 Recruiting April 21, 2026
Predictive Factors and Subthalamic Stimulation in Parkinson's Disease Trial N/A Completed April 21, 2026
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology Trial N/A Not yet recruiting April 21, 2026